USDA‑funded grove studies of TPR1 target a multibillion‑dollar crop loss problem while the new EPO patent locks in protection for the core molecule a USDA‑selected compound already in Ph 2 grove ...
(MENAFN- EIN Presswire) EINPresswire/ -- Pop Test Oncology LLC, operating as Palisades Therapeutics, today announced that the European Patent Office (EPO) has granted European Patent EP 3 534 910 B1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results